世界のフラグメント創薬(FBDD)市場インサイト及び予測(~2026年)

【英語タイトル】Global Fragment-based Drug Discovery Market Size, Status and Forecast 2020-2026

QYResearchが出版した調査資料(QYR20NV11991)・商品コード:QYR20NV11991
・発行会社(調査会社):QYResearch
・発行日:2020年11月
・ページ数:95
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥421,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥631,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥842,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートはフラグメント創薬(FBDD)の世界市場について調査・分析した資料です。種類別(フラグメントスクリーニング、フラグメント最適化)の市場規模、用途別(バイオ製薬会社、CRO、学術・研究機関)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別フラグメント創薬(FBDD)の競争状況、市場シェア
・世界のフラグメント創薬(FBDD)市場:種類別市場規模 2015年-2020年(フラグメントスクリーニング、フラグメント最適化)
・世界のフラグメント創薬(FBDD)市場:種類別市場規模予測 2021年-2026年(フラグメントスクリーニング、フラグメント最適化)
・世界のフラグメント創薬(FBDD)市場:用途別市場規模 2015年-2020年(バイオ製薬会社、CRO、学術・研究機関)
・世界のフラグメント創薬(FBDD)市場:用途別市場規模予測 2021年-2026年(バイオ製薬会社、CRO、学術・研究機関)
・北米のフラグメント創薬(FBDD)市場分析:米国、カナダ
・ヨーロッパのフラグメント創薬(FBDD)市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのフラグメント創薬(FBDD)市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のフラグメント創薬(FBDD)市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのフラグメント創薬(FBDD)市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Astex Pharmaceuticals、Alveus Pharmaceuticals、Beactica、Charles River Laboratories、Crown Bioscience、Emerald BioStructures、Evotec、Kinetic Discovery、Proteros Fragments、Sprint Bioscience、Structure Based Design、Sygnature Discovery
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

The introduction of new techniques into the existing fragment-based drug discovery practices have created significant reductions in time and cost, driving the demand for such practices.

Market Analysis and Insights: Global Fragment-based Drug Discovery Market
The global Fragment-based Drug Discovery market size is projected to reach US$ 343.1 million by 2026, from US$ 320.5 million in 2020, at a CAGR of 6.5%% during 2021-2026.

Global Fragment-based Drug Discovery Scope and Market Size
Fragment-based Drug Discovery market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Fragment-based Drug Discovery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Astex Pharmaceuticals
Alveus Pharmaceuticals
Beactica
Charles River Laboratories
Crown Bioscience
Emerald BioStructures
Evotec
Kinetic Discovery
Proteros Fragments
Sprint Bioscience
Structure Based Design
Sygnature Discovery

Market segment by Type, the product can be split into
Fragment Screening
Fragment Optimization
Market segment by Application, split into
Biopharmaceutical Companies
CROs
Academic and Research Institutions

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Fragment-based Drug Discovery Revenue
1.4 Market by Type
1.4.1 Global Fragment-based Drug Discovery Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Fragment Screening
1.4.3 Fragment Optimization
1.5 Market by Application
1.5.1 Global Fragment-based Drug Discovery Market Share by Application: 2020 VS 2026
1.5.2 Biopharmaceutical Companies
1.5.3 CROs
1.5.4 Academic and Research Institutions
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Fragment-based Drug Discovery Market Perspective (2015-2026)
2.2 Global Fragment-based Drug Discovery Growth Trends by Regions
2.2.1 Fragment-based Drug Discovery Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Fragment-based Drug Discovery Historic Market Share by Regions (2015-2020)
2.2.3 Fragment-based Drug Discovery Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Fragment-based Drug Discovery Market Growth Strategy
2.3.6 Primary Interviews with Key Fragment-based Drug Discovery Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Fragment-based Drug Discovery Players by Market Size
3.1.1 Global Top Fragment-based Drug Discovery Players by Revenue (2015-2020)
3.1.2 Global Fragment-based Drug Discovery Revenue Market Share by Players (2015-2020)
3.1.3 Global Fragment-based Drug Discovery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Fragment-based Drug Discovery Market Concentration Ratio
3.2.1 Global Fragment-based Drug Discovery Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Fragment-based Drug Discovery Revenue in 2019
3.3 Fragment-based Drug Discovery Key Players Head office and Area Served
3.4 Key Players Fragment-based Drug Discovery Product Solution and Service
3.5 Date of Enter into Fragment-based Drug Discovery Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Fragment-based Drug Discovery Historic Market Size by Type (2015-2020)
4.2 Global Fragment-based Drug Discovery Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Fragment-based Drug Discovery Market Size by Application (2015-2020)
5.2 Global Fragment-based Drug Discovery Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Fragment-based Drug Discovery Market Size (2015-2020)
6.2 Fragment-based Drug Discovery Key Players in North America (2019-2020)
6.3 North America Fragment-based Drug Discovery Market Size by Type (2015-2020)
6.4 North America Fragment-based Drug Discovery Market Size by Application (2015-2020)

7 Europe
7.1 Europe Fragment-based Drug Discovery Market Size (2015-2020)
7.2 Fragment-based Drug Discovery Key Players in Europe (2019-2020)
7.3 Europe Fragment-based Drug Discovery Market Size by Type (2015-2020)
7.4 Europe Fragment-based Drug Discovery Market Size by Application (2015-2020)

8 China
8.1 China Fragment-based Drug Discovery Market Size (2015-2020)
8.2 Fragment-based Drug Discovery Key Players in China (2019-2020)
8.3 China Fragment-based Drug Discovery Market Size by Type (2015-2020)
8.4 China Fragment-based Drug Discovery Market Size by Application (2015-2020)

9 Japan
9.1 Japan Fragment-based Drug Discovery Market Size (2015-2020)
9.2 Fragment-based Drug Discovery Key Players in Japan (2019-2020)
9.3 Japan Fragment-based Drug Discovery Market Size by Type (2015-2020)
9.4 Japan Fragment-based Drug Discovery Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Fragment-based Drug Discovery Market Size (2015-2020)
10.2 Fragment-based Drug Discovery Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Fragment-based Drug Discovery Market Size by Type (2015-2020)
10.4 Southeast Asia Fragment-based Drug Discovery Market Size by Application (2015-2020)

11 India
11.1 India Fragment-based Drug Discovery Market Size (2015-2020)
11.2 Fragment-based Drug Discovery Key Players in India (2019-2020)
11.3 India Fragment-based Drug Discovery Market Size by Type (2015-2020)
11.4 India Fragment-based Drug Discovery Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Fragment-based Drug Discovery Market Size (2015-2020)
12.2 Fragment-based Drug Discovery Key Players in Central & South America (2019-2020)
12.3 Central & South America Fragment-based Drug Discovery Market Size by Type (2015-2020)
12.4 Central & South America Fragment-based Drug Discovery Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Astex Pharmaceuticals
13.1.1 Astex Pharmaceuticals Company Details
13.1.2 Astex Pharmaceuticals Business Overview
13.1.3 Astex Pharmaceuticals Fragment-based Drug Discovery Introduction
13.1.4 Astex Pharmaceuticals Revenue in Fragment-based Drug Discovery Business (2015-2020))
13.1.5 Astex Pharmaceuticals Recent Development
13.2 Alveus Pharmaceuticals
13.2.1 Alveus Pharmaceuticals Company Details
13.2.2 Alveus Pharmaceuticals Business Overview
13.2.3 Alveus Pharmaceuticals Fragment-based Drug Discovery Introduction
13.2.4 Alveus Pharmaceuticals Revenue in Fragment-based Drug Discovery Business (2015-2020)
13.2.5 Alveus Pharmaceuticals Recent Development
13.3 Beactica
13.3.1 Beactica Company Details
13.3.2 Beactica Business Overview
13.3.3 Beactica Fragment-based Drug Discovery Introduction
13.3.4 Beactica Revenue in Fragment-based Drug Discovery Business (2015-2020)
13.3.5 Beactica Recent Development
13.4 Charles River Laboratories
13.4.1 Charles River Laboratories Company Details
13.4.2 Charles River Laboratories Business Overview
13.4.3 Charles River Laboratories Fragment-based Drug Discovery Introduction
13.4.4 Charles River Laboratories Revenue in Fragment-based Drug Discovery Business (2015-2020)
13.4.5 Charles River Laboratories Recent Development
13.5 Crown Bioscience
13.5.1 Crown Bioscience Company Details
13.5.2 Crown Bioscience Business Overview
13.5.3 Crown Bioscience Fragment-based Drug Discovery Introduction
13.5.4 Crown Bioscience Revenue in Fragment-based Drug Discovery Business (2015-2020)
13.5.5 Crown Bioscience Recent Development
13.6 Emerald BioStructures
13.6.1 Emerald BioStructures Company Details
13.6.2 Emerald BioStructures Business Overview
13.6.3 Emerald BioStructures Fragment-based Drug Discovery Introduction
13.6.4 Emerald BioStructures Revenue in Fragment-based Drug Discovery Business (2015-2020)
13.6.5 Emerald BioStructures Recent Development
13.7 Evotec
13.7.1 Evotec Company Details
13.7.2 Evotec Business Overview
13.7.3 Evotec Fragment-based Drug Discovery Introduction
13.7.4 Evotec Revenue in Fragment-based Drug Discovery Business (2015-2020)
13.7.5 Evotec Recent Development
13.8 Kinetic Discovery
13.8.1 Kinetic Discovery Company Details
13.8.2 Kinetic Discovery Business Overview
13.8.3 Kinetic Discovery Fragment-based Drug Discovery Introduction
13.8.4 Kinetic Discovery Revenue in Fragment-based Drug Discovery Business (2015-2020)
13.8.5 Kinetic Discovery Recent Development
13.9 Proteros Fragments
13.9.1 Proteros Fragments Company Details
13.9.2 Proteros Fragments Business Overview
13.9.3 Proteros Fragments Fragment-based Drug Discovery Introduction
13.9.4 Proteros Fragments Revenue in Fragment-based Drug Discovery Business (2015-2020)
13.9.5 Proteros Fragments Recent Development
13.10 Sprint Bioscience
13.10.1 Sprint Bioscience Company Details
13.10.2 Sprint Bioscience Business Overview
13.10.3 Sprint Bioscience Fragment-based Drug Discovery Introduction
13.10.4 Sprint Bioscience Revenue in Fragment-based Drug Discovery Business (2015-2020)
13.10.5 Sprint Bioscience Recent Development
13.11 Structure Based Design
10.11.1 Structure Based Design Company Details
10.11.2 Structure Based Design Business Overview
10.11.3 Structure Based Design Fragment-based Drug Discovery Introduction
10.11.4 Structure Based Design Revenue in Fragment-based Drug Discovery Business (2015-2020)
10.11.5 Structure Based Design Recent Development
13.12 Sygnature Discovery
10.12.1 Sygnature Discovery Company Details
10.12.2 Sygnature Discovery Business Overview
10.12.3 Sygnature Discovery Fragment-based Drug Discovery Introduction
10.12.4 Sygnature Discovery Revenue in Fragment-based Drug Discovery Business (2015-2020)
10.12.5 Sygnature Discovery Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Fragment-based Drug Discovery Key Market Segments
Table 2. Key Players Covered: Ranking by Fragment-based Drug Discovery Revenue
Table 3. Ranking of Global Top Fragment-based Drug Discovery Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Fragment-based Drug Discovery Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Fragment Screening
Table 6. Key Players of Fragment Optimization
Table 7. Global Fragment-based Drug Discovery Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Fragment-based Drug Discovery Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Fragment-based Drug Discovery Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Fragment-based Drug Discovery Market Share by Regions (2015-2020)
Table 11. Global Fragment-based Drug Discovery Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Fragment-based Drug Discovery Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Fragment-based Drug Discovery Market Growth Strategy
Table 17. Main Points Interviewed from Key Fragment-based Drug Discovery Players
Table 18. Global Fragment-based Drug Discovery Revenue by Players (2015-2020) (Million US$)
Table 19. Global Fragment-based Drug Discovery Market Share by Players (2015-2020)
Table 20. Global Top Fragment-based Drug Discovery Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fragment-based Drug Discovery as of 2019)
Table 21. Global Fragment-based Drug Discovery by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Fragment-based Drug Discovery Product Solution and Service
Table 24. Date of Enter into Fragment-based Drug Discovery Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Fragment-based Drug Discovery Market Size by Type (2015-2020) (Million US$)
Table 27. Global Fragment-based Drug Discovery Market Size Share by Type (2015-2020)
Table 28. Global Fragment-based Drug Discovery Revenue Market Share by Type (2021-2026)
Table 29. Global Fragment-based Drug Discovery Market Size Share by Application (2015-2020)
Table 30. Global Fragment-based Drug Discovery Market Size by Application (2015-2020) (Million US$)
Table 31. Global Fragment-based Drug Discovery Market Size Share by Application (2021-2026)
Table 32. North America Key Players Fragment-based Drug Discovery Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Fragment-based Drug Discovery Market Share (2019-2020)
Table 34. North America Fragment-based Drug Discovery Market Size by Type (2015-2020) (Million US$)
Table 35. North America Fragment-based Drug Discovery Market Share by Type (2015-2020)
Table 36. North America Fragment-based Drug Discovery Market Size by Application (2015-2020) (Million US$)
Table 37. North America Fragment-based Drug Discovery Market Share by Application (2015-2020)
Table 38. Europe Key Players Fragment-based Drug Discovery Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Fragment-based Drug Discovery Market Share (2019-2020)
Table 40. Europe Fragment-based Drug Discovery Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Fragment-based Drug Discovery Market Share by Type (2015-2020)
Table 42. Europe Fragment-based Drug Discovery Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Fragment-based Drug Discovery Market Share by Application (2015-2020)
Table 44. China Key Players Fragment-based Drug Discovery Revenue (2019-2020) (Million US$)
Table 45. China Key Players Fragment-based Drug Discovery Market Share (2019-2020)
Table 46. China Fragment-based Drug Discovery Market Size by Type (2015-2020) (Million US$)
Table 47. China Fragment-based Drug Discovery Market Share by Type (2015-2020)
Table 48. China Fragment-based Drug Discovery Market Size by Application (2015-2020) (Million US$)
Table 49. China Fragment-based Drug Discovery Market Share by Application (2015-2020)
Table 50. Japan Key Players Fragment-based Drug Discovery Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Fragment-based Drug Discovery Market Share (2019-2020)
Table 52. Japan Fragment-based Drug Discovery Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Fragment-based Drug Discovery Market Share by Type (2015-2020)
Table 54. Japan Fragment-based Drug Discovery Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Fragment-based Drug Discovery Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Fragment-based Drug Discovery Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Fragment-based Drug Discovery Market Share (2019-2020)
Table 58. Southeast Asia Fragment-based Drug Discovery Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Fragment-based Drug Discovery Market Share by Type (2015-2020)
Table 60. Southeast Asia Fragment-based Drug Discovery Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Fragment-based Drug Discovery Market Share by Application (2015-2020)
Table 62. India Key Players Fragment-based Drug Discovery Revenue (2019-2020) (Million US$)
Table 63. India Key Players Fragment-based Drug Discovery Market Share (2019-2020)
Table 64. India Fragment-based Drug Discovery Market Size by Type (2015-2020) (Million US$)
Table 65. India Fragment-based Drug Discovery Market Share by Type (2015-2020)
Table 66. India Fragment-based Drug Discovery Market Size by Application (2015-2020) (Million US$)
Table 67. India Fragment-based Drug Discovery Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Fragment-based Drug Discovery Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Fragment-based Drug Discovery Market Share (2019-2020)
Table 70. Central & South America Fragment-based Drug Discovery Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Fragment-based Drug Discovery Market Share by Type (2015-2020)
Table 72. Central & South America Fragment-based Drug Discovery Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Fragment-based Drug Discovery Market Share by Application (2015-2020)
Table 74. Astex Pharmaceuticals Company Details
Table 75. Astex Pharmaceuticals Business Overview
Table 76. Astex Pharmaceuticals Product
Table 77. Astex Pharmaceuticals Revenue in Fragment-based Drug Discovery Business (2015-2020) (Million US$)
Table 78. Astex Pharmaceuticals Recent Development
Table 79. Alveus Pharmaceuticals Company Details
Table 80. Alveus Pharmaceuticals Business Overview
Table 81. Alveus Pharmaceuticals Product
Table 82. Alveus Pharmaceuticals Revenue in Fragment-based Drug Discovery Business (2015-2020) (Million US$)
Table 83. Alveus Pharmaceuticals Recent Development
Table 84. Beactica Company Details
Table 85. Beactica Business Overview
Table 86. Beactica Product
Table 87. Beactica Revenue in Fragment-based Drug Discovery Business (2015-2020) (Million US$)
Table 88. Beactica Recent Development
Table 89. Charles River Laboratories Company Details
Table 90. Charles River Laboratories Business Overview
Table 91. Charles River Laboratories Product
Table 92. Charles River Laboratories Revenue in Fragment-based Drug Discovery Business (2015-2020) (Million US$)
Table 93. Charles River Laboratories Recent Development
Table 94. Crown Bioscience Company Details
Table 95. Crown Bioscience Business Overview
Table 96. Crown Bioscience Product
Table 97. Crown Bioscience Revenue in Fragment-based Drug Discovery Business (2015-2020) (Million US$)
Table 98. Crown Bioscience Recent Development
Table 99. Emerald BioStructures Company Details
Table 100. Emerald BioStructures Business Overview
Table 101. Emerald BioStructures Product
Table 102. Emerald BioStructures Revenue in Fragment-based Drug Discovery Business (2015-2020) (Million US$)
Table 103. Emerald BioStructures Recent Development
Table 104. Evotec Company Details
Table 105. Evotec Business Overview
Table 106. Evotec Product
Table 107. Evotec Revenue in Fragment-based Drug Discovery Business (2015-2020) (Million US$)
Table 108. Evotec Recent Development
Table 109. Kinetic Discovery Business Overview
Table 110. Kinetic Discovery Product
Table 111. Kinetic Discovery Company Details
Table 112. Kinetic Discovery Revenue in Fragment-based Drug Discovery Business (2015-2020) (Million US$)
Table 113. Kinetic Discovery Recent Development
Table 114. Proteros Fragments Company Details
Table 115. Proteros Fragments Business Overview
Table 116. Proteros Fragments Product
Table 117. Proteros Fragments Revenue in Fragment-based Drug Discovery Business (2015-2020) (Million US$)
Table 118. Proteros Fragments Recent Development
Table 119. Sprint Bioscience Company Details
Table 120. Sprint Bioscience Business Overview
Table 121. Sprint Bioscience Product
Table 122. Sprint Bioscience Revenue in Fragment-based Drug Discovery Business (2015-2020) (Million US$)
Table 123. Sprint Bioscience Recent Development
Table 124. Structure Based Design Company Details
Table 125. Structure Based Design Business Overview
Table 126. Structure Based Design Product
Table 127. Structure Based Design Revenue in Fragment-based Drug Discovery Business (2015-2020) (Million US$)
Table 128. Structure Based Design Recent Development
Table 129. Sygnature Discovery Company Details
Table 130. Sygnature Discovery Business Overview
Table 131. Sygnature Discovery Product
Table 132. Sygnature Discovery Revenue in Fragment-based Drug Discovery Business (2015-2020) (Million US$)
Table 133. Sygnature Discovery Recent Development
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Fragment-based Drug Discovery Market Share by Type: 2020 VS 2026
Figure 2. Fragment Screening Features
Figure 3. Fragment Optimization Features
Figure 4. Global Fragment-based Drug Discovery Market Share by Application: 2020 VS 2026
Figure 5. Biopharmaceutical Companies Case Studies
Figure 6. CROs Case Studies
Figure 7. Academic and Research Institutions Case Studies
Figure 8. Fragment-based Drug Discovery Report Years Considered
Figure 9. Global Fragment-based Drug Discovery Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Fragment-based Drug Discovery Market Share by Regions: 2020 VS 2026
Figure 11. Global Fragment-based Drug Discovery Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Fragment-based Drug Discovery Market Share by Players in 2019
Figure 14. Global Top Fragment-based Drug Discovery Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fragment-based Drug Discovery as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Fragment-based Drug Discovery Revenue in 2019
Figure 16. North America Fragment-based Drug Discovery Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Fragment-based Drug Discovery Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Fragment-based Drug Discovery Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Fragment-based Drug Discovery Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Fragment-based Drug Discovery Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Fragment-based Drug Discovery Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Fragment-based Drug Discovery Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed


【掲載企業】

Astex Pharmaceuticals、Alveus Pharmaceuticals、Beactica、Charles River Laboratories、Crown Bioscience、Emerald BioStructures、Evotec、Kinetic Discovery、Proteros Fragments、Sprint Bioscience、Structure Based Design、Sygnature Discovery

★調査レポート[世界のフラグメント創薬(FBDD)市場インサイト及び予測(~2026年)] (コード:QYR20NV11991)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のフラグメント創薬(FBDD)市場インサイト及び予測(~2026年)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆